Navigation Links
Missouri Doctor, David Barbe, M.D., Newly Elected to AMA Board of Trustees
Date:6/16/2009

CHICAGO, June 16 /PRNewswire-USNewswire/ -- David O. Barbe, M.D., a practicing family physician, was elected today as the newest member of the Board of Trustees of the American Medical Association.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO )

"I am honored to be elected to the AMA Board of Trustees," said Dr. Barbe. "I look forward to representing physicians as the AMA and the nation focus on health-care reform."

Dr. Barbe's multifaceted career spans nearly three decades of service, including many top leadership positions in his local, state and family practice specialty organizations. He has served on the AMA's Council of Medical Service for two terms, acting this year as its chair. Dr. Barbe has also chaired the Council's subcommittee on medical payment and financing. He has served on the AMA's Physicians Data Release Task Force and as the AMA designee to URAC, an accreditation body.

Dr. Barbe has practiced family medicine in his hometown of Mountain Grove, Missouri for 25 years, delivering comprehensive medical care including pediatrics, obstetrics and adult medicine. He also oversees all clinic operations of St. John's Clinic, Regional Division, in southwest Missouri and northwest Arkansas.

Dr. Barbe received his medical degree and Master of Health Administration from the University of Missouri and completed his residency in family practice in Wichita, Kansas. Dr. Barbe and his wife, Debbie, currently live in Mountain Grove, Missouri.

Dr. Barbe's term on the Board lasts four years.


'/>"/>
SOURCE American Medical Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Missouri Children to Mitt Romney: Show Me Your Health Care Priorities
2. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
3. University of Missouri Veterinarian Wins Americas Best Vet Honor; Four Regional Winners Also Named
4. TriWest Contributes $15,000 to Missouri National Guard Fund
5. Grubb & Ellis Healthcare REIT Acquires Chesterfield Rehabilitation Center in Chesterfield, Missouri in a Joint Venture with Duke Realty
6. MU research team releases first Missouri Hunger Atlas
7. ACS Announces $57 Million Contract With Missouri HealthNet
8. The SCOOTER Store Donates Power Wheelchair to Terminally Ill Great-Grandfather in Missouri
9. Sanford-Brown College Students Help in Missouri Flood Relief
10. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
11. Leading Neurologist Opens Missouri Baptist Medical Centers First MS Center
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5